The Community Focus Channel is supported with funding from Johnson & Johnson (Gold).
The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EHA 2026 | Diagnosing PCNSL: key considerations and assessing for vitreoretinal involvement
Maurilio Ponzoni, MD, Vita Salute University San Raffaele, Milan, Italy, discusses key diagnostic considerations in primary central nervous system lymphoma (PCNSL), emphasizing prompt stereotactic biopsy before corticosteroid use. Prof. Ponzoni also highlights the importance of the slit lamp examination in assessing for vitreoretinal involvement and obtaining brain MRI in patients diagnosed with primary vitreoretinal lymphoma to assess for concurrent CNS disease. This interview took place at the 31st Congress of the European Hematology Association (EHA) in Stockholm, Sweden.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
